Company Profile 830 Winter Street Waltham, MA 02451 United States 781-895-0600 http://www.immunogen.com Sector: Healthcare Industry: Biotechnology Full Time Employees: 308 ImmunoGen, Inc., a clinical-stage biotechnology company, develops targeted anticancer therapeutics. The company develops its products using its antibody-drug conjugate (ADC) technology. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha for the treatment of platinum-resistant ovarian cancer; IMGN529, an ADC that is in Phase 1b/2 clinical trials for B-cell malignancies; coltuximab ravtansine, which is in Phase 2 trials for B-cell malignancies; IMGN779 that is in Phase 1 clinical trials for the treatment of acute myeloid leukemia (AML); and IMGN632, a preclinical CD123-targeting ADC for the treatment of hematological malignancies, including AML. ImmunoGen, Inc. has collaborations with Roche; Bayer HealthCare AG; Sanofi; Biotest AG; Novartis Institutes for BioMedical Research, Inc.; Eli Lilly and Company; Amgen; Takeda Pharmaceutical Company Limited; Merck; and CytomX Therapeutics, Inc. ImmunoGen, Inc. was founded in 1981 and is headquartered in Waltham, Massachusetts. Statistics https://finance.yahoo.com/quote/IMGN/key-statistics?p=IMGN Holders https://finance.yahoo.com/quote/IMGN/holders?p=IMGN
latest news Jul-29-17 05:19PM Edited Transcript of IMGN earnings conference call or presentation 28-Jul-17 12:00pm GMT Thomson Reuters StreetEvents Jul-28-17 10:01PM ImmunoGen reports 2Q loss Associated Press +14.29% 05:05PM Why Shares of ImmunoGen Inc. Shot Up Today Motley Fool 12:43PM Despite Decline in Global Markets, Several Stocks Are Jumping GuruFocus.com 07:34AM ImmunoGen (IMGN) Reports Narrower-than-Expected Q2 Loss Zacks ul-25-17 04:25PM Three biotech companies to watch ahead of earnings MarketWatch Jul-24-17 04:16PM Why ImmunoGen, Inc. Jumped Higher Today Motley Fool +12.01%
At close: July 28 4:00PM EDT 6.96+0.87 (+14.29%) A/H $7.11 +0.15 +2.16% Day's Range 6.29 - 7.15 52 Week Range 1.51 - 8.04 Volume 8,234,573 Avg. Volume 2,921,425 Resist. 8.04 - 9.39 Sup. 6.45 one of my latest scalp's stock... IMO next could be 8 but could test the sup still... DYOR + DD
Very interesting - seems to be little resistance until $9 although the previous high of $8 (as you say) might be the next challenge?
As you know, was a great play for me from the $4' s and then became a great short after ER. Was bouncing back up from 50 ma but has broken through to the downside so may be heading to lower $5's. Here's What Pushed ImmunoGen, Inc. Stock 16.5% Lower in July - https://www.fool.com/investing/2017/08/02/heres-what-pushed-immunogen-inc-stock-165-lower-in.aspx
I agree - after a burst of life it seems to be headed downward just now. The classic pump and dump for short term traders?
Nice little bounce from lower $5's support area but not enough vol to push it through 50 ma but trader interest might do it but not so sure about that either b/c looks like it might be awhile before anything significant comes from company.
The shares need to stay above support levels for a few days before I would even consider buying - in that grey area at the moment when it looks like they are moving out of the down trend but could so easily slip back into it. Watch from the sidelines for now. Price $5.82 @ 7 Aug 2017
^^ am more of a swing/day trader so will play the chart and had a nice pop to $6.18 today before fading which is $1.01 per share for anyone that caught it @ $5.17 end of last week and that's not bad money!
Looks like the shares are heading for the next resistance level around $6.50. A safer buy when they go over but perhaps a buy now for the brave? Price $6.12 @ 16 Aug 2017
